Clinical Trials Browser

Phase 3 × NIH × Amyloidosis × Clear all

NCT01078454 2022-02-01

Melphalan and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Systemic Light-Chain Amyloidosis

Phase 3 Completed

11 enrolled 6 charts

Immunoglobulin Light-chain Amyloidosis, Amyloidosis